<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="190031">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00619437</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-07-4620-RG-CTIL</org_study_id>
    <nct_id>NCT00619437</nct_id>
  </id_info>
  <brief_title>Genetics of Schizophrenia</brief_title>
  <official_title>Genetics of Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Genetic etiology in schizophrenia is widely accepted. However, many chromosomal sites were
      shown to characterize the families of patients with schizophrenia. This is probably due to
      the high genetic heterogenity of this illness. Thus, it is important to investigate the
      genetic factor in relatively genetically homogenous populations. Many studies have indicate
      that Ashkenazy Jews show relative gentic homogenity. Indeed, the genes responsible for most
      Mendelian disorders of Jewish peoples have been identified. The study will apply genome-wide
      mutation screening methods to identify candidate allells in subjects of Ashkenazi Jewish
      ancestry with multiplex schizophrenia.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2008</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Schizophrenia</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cell Lines / DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        schizophrenia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18+;

          2. Meet DSM-IV criteria for Schizophrenia;

          3. At least one first-degree relative who Meet DSM-IV criteria for Schizophrenia;

          4. Can sign the informed consent form.

        Exclusion Criteria:

          1. Patients suffering from terminal or incurabale disease;

          2. Minors, incompetents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>78 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Bunzel, MD</last_name>
    <role>Study Director</role>
    <affiliation>Psychiatric ward, Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raz Gross, MD, MPH</last_name>
    <phone>972 3 530 3962</phone>
    <email>razg@gertner.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Bunzel, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michael Bunzel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <lastchanged_date>February 10, 2008</lastchanged_date>
  <firstreceived_date>February 10, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Raz Gross, Head</name_title>
    <organization>Mental Health Epidemiology, The Gertner Institute for Epidemiology</organization>
  </responsible_party>
  <keyword>schizophrenia</keyword>
  <keyword>genetics</keyword>
  <keyword>family</keyword>
  <keyword>multiplex</keyword>
  <keyword>haplotypes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
